From the Editor: Using PCSK9 inhibitors in practice
J Clin Lipidol
.
2017 Jul-Aug;11(4):843-844.
doi: 10.1016/j.jacl.2017.06.009.
Epub 2017 Jun 28.
Author
William Virgil Brown
1
Affiliation
1
Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: editorjcl@lipid.org.
PMID:
28689848
DOI:
10.1016/j.jacl.2017.06.009
No abstract available
Publication types
Editorial
MeSH terms
Anticholesteremic Agents / pharmacology*
Cholesterol, LDL / blood
Humans
PCSK9 Inhibitors*
Protease Inhibitors / pharmacology*
Substances
Anticholesteremic Agents
Cholesterol, LDL
PCSK9 Inhibitors
Protease Inhibitors